NASDAQ:CLVS

Clovis Oncology Earning Date

USA |NASDAQ |USD

CLVS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.48 $-0.61 $-0.89
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $39.09M $36.82M $38.77M

Clovis Oncology's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

CLVS Earnings Date & History Chart

CLVS Earnings & Revenue Forecast

CLVS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.51 $-0.76 $-0.41
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-2.23 $-2.49 $-2.06
Dec 2022 6 $-1.36 $-1.86 $-0.80

CLVS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.51 $-0.51 $-0.56
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-2.22 $-2.22 $-2.27
Dec 2022 0 / 1 $-1.34 $-1.34 $-1.20

CLVS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $41.76M $38.30M $45.76M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $155.56M $150.50M $161.14M
Dec 2022 6 $207.57M $189.00M $231.07M

CLVS Earnings Date & Revenue History

CLVS Earnings History

|
Show More
Show More

CLVS Revenue History

|
Show More
Show More

Clovis Oncology Next Earnings Date & Report

CLVS Next Earnings Date & Report Preview: Sep 2021 (FQ)

CLVS's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Clovis Oncology's next quarterly earnings is $-0.48, with a low EPS estimation of $-0.54, and a high estimation of $-0.44.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.49, the last 2 month trend is $-0.49, and the 3 month trend is $-0.52.

Based on 6 analysts, the average revenue estimation is $39.09M, with a low revenue estimation of $37.30M, and a high estimation of $40.50M.

Clovis Oncology Previous Earnings Dates & Reports

CLVS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Clovis Oncology's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

CLVS's earnings per share (EPS) was $-0.61, missing the consensus analysts forecast of $-0.57 by -6.70%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -4.69%, and higher than the same period a year before (Jun 2020) by -46.96%.

Revenues were $36.82M, better than the forecast of $36.82M by 0.00%, down by -3.24% from the previous quarter , and down by -7.69% from the same period last year.

The company reported a net income of $-66.45M.

Free cash flow for the quarter was $-46.79M , compared to $-62.01M last quarter and $-67.90M a year before.

CLVS ended the quarter with $672.63M in total debt, an increase of 1.26% compared to the previous quarter, and an increase of 9.20% compared to the same quarter a year before.

CLVS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Clovis Oncology's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

CLVS's earnings per share (EPS) was $-4.45, missing the consensus analysts forecast of $-4.01 by 10.97% , and higher than the previous year's EPS (Dec 2019) by -40.11%.

Revenues were $164.52M, better than the forecast of $164.39M by 0.08%, and up by 15.05% from previous year's revenue.

The company reported a net income of $-369.21M.

Clovis Oncology reported a free cash flow of $-261.08M for its fiscal year, compared to $-342.65M a year ago.

The company ended the fiscal year with $615.29M in total debt, a decrease of -10.20% compared to the previous year.